Loading...
The bovine gelatin market is expected to grow from USD 2.014 billion in 2025 to USD 2.886 billion in 2030, at a CAGR of 7.46%.
Bovine gelatin is a gelling substance made of proteins from animal tissue such as the skin and bone marrow of cows, oxen, or buffalo. The collagen protein is taken out from the bovine hide and bone marrow and is partially hydrolyzed to convert it into gelatin form. Since gelatin scarcely includes any fat, fibre, sugar, carbohydrates, or other vitamins and minerals in its biochemical composition, it is referred to as a "pure protein." Bovine gelatin contains between 98 and 99 percent protein.
Bovine gelatin has customers in a wide range of end-user industry verticals such as pharmaceuticals, food and beverage, cosmetics and personal care, nutraceutical industry, etc., which is driving the growth of the global market A further factor driving market expansion is the health advantages of consuming bovine gelatin. Since bovine gelatin has the ability to shield skin against problems like zits, blemishes, and tanning, it is frequently employed in cosmetics and skincare products. The need for cosmetic treatments and skincare, hair care, and personal care products is anticipated to expand, supporting the bovine gelatin market.
However, the growing adoption of vegetarian and vegan diets, allergies associated with the consumption of bovine products rising incidences of diseases among cattle, and the availability of alternatives are some of the factors that will hinder the growth of the global bovine gelatin market.
Bovine gelatin is used as an additive for thickening purposes while cooking or baking. Its ability to absorb liquid and create a gel or jelly consistency, in desserts such as jams, gummies, puddings, marshmallows, and jellies. It is used as a “texturizer” “stabilizer” and binding agent in various dessert recipes. As a result, the growing food and beverage industry, especially the confectionary segment will propel the growth of the market during the projection period. According to the National Committee on Accreditation data, in 2020, United States sales for confectionary products reached USD 36.7 billion.
Hard capsules, tablets and soft gels are made using bovine gelatin as an excipient substance and binding agent. It has less complicated manufacturing processes and reduced production costs. Additionally, it aids in shielding delicate substances of medicines from microbial development, air, light, and other types of pollution. Bovine gelatin is also used as a stabilizing agent in vaccines. As a result, the expansion of the pharmaceutical and healthcare industry will aid the expansion of the global market. According to a report published by the European Federation of Pharmaceutical Industries and Associations, data shows, In 2020, North America made up 49.0% of global pharmaceutical revenues, compared to Europe's 23.9 percent. According to IQVIA, the US market accounted for 63.7 percent of sales of new medications introduced between 2015 and 2020, while the European market accounted for 17.4 percent.
Bovine gelatin is an additive that is made using the hide and bone of animals such as cows, oxen, and buffalos. The food and beverage sector is one the largest consumers of bovine gelatin around the world. Bovine gelatin is extensively used in the production of confectionery products. The rising shift of consumers towards veganism and vegetarianism is expected to restrict the market growth during the forecast period. A vegan diet has never been more popular now. It has been spurred by causes such as sustainability, health, animal cruelty, and the present climate change problem. According to Vegan Society data, as of January 2021, there are around 79 million vegans worldwide. The rapid adoption of vegan and vegetarian diets around the globe is forcing end product manufacturers to come up with vegan and veg alternatives for consumers.
North American region is anticipated to hold a significant amount of market share in bovine or beef gelatin. The presence of leading market firms like Bernard Jensen, Darling Ingredients etc is propelling growth in the region. Well-established pharmaceutical and food & beverage sectors in countries like the United States are driving growth in the North American region. According to the EFPIA report, the United States is a center of innovation and home to top pharmaceutical, biopharmaceutical, and drug development businesses. In 2020, North America made up 49.0% of global pharmaceutical revenues. According to IQVIA, the US market accounted for 63.7 percent of sales of new medications introduced between 2015 and 2020, while the European market accounted for 17.4 percent. The prime market in North America includes Canada, the United States, and Mexico.
Segmentation